Use of statins and blood pressure

被引:36
作者
King, Dana E. [1 ]
Mainous, Arch G., III [1 ]
Egan, Brent M. [1 ]
Player, Marty [1 ]
Geesey, Mark E. [1 ]
机构
[1] Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA
关键词
statins; blood pressure; hypertension; inflammation; C-reactive protein;
D O I
10.1016/j.amjhyper.2007.03.018
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Markers of inflammation such as highsensitivity C-reactive protein (CRP) were shown to be elevated in patients with hypertension. Small trials using statin therapy showed blood-pressure (BP) reductions, but it is unknown whether this association extends to larger populations. The objective of this study was to determine whether statin use was associated with better blood-pressure control in adults with hypertension and whether inflammation levels mediated this relationship. Methods: This was a cross-sectional study of 2584 hypertensive adults aged >= 40 years with no known cardiovascular disease from the National Health and Nutrition Examination Survey 1999-2002. Logistic regression models were calculated to determine whether there was an association between statin use and blood-pressure control. C-reactive protein was added to the full model to determine its impact on the association. Results: Compared with people not using statin medication, significantly more statin users had their blood pressure under control (52.2% v 38.0%). After adjustment for demographic factors, statin users were two times (95% confidence interval [CI], 1.46 to 2.72) more likely to have their blood pressure under control (<140/90 mm Hg) than nonusers. After further adjustment for body mass index, diabetes, smoking, exercise, low-salt diet, and antihypertensive medications, the likelihood of having blood pressure under control remained more likely among statin users (odds ratio, 1.46; 95% CI, 1.05 to 2.05). The association between statin use and lower BP was most evident among participants who used antihypertensive medication as well as statins and was unchanged with the addition of CRP to the model. Conclusions: Stalin use was associated with a BP level <140/90 mm Hg in a representative sample of US adults with hypertension. Levels of CRP did not attenuate the association. Further studies are needed to explore the effects of statin use on blood pressure and to determine how best to apply this knowledge in clinical care.
引用
收藏
页码:937 / 941
页数:5
相关论文
共 16 条
[11]   Statins: another class of antihypertensive agents? [J].
Milionis, HJ ;
Liberopoulos, EN ;
Achimastos, A ;
Elisaf, MS ;
Mikhailidis, DP .
JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (05) :320-335
[12]   Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].
Pearson, TA ;
Mensah, GA ;
Alexander, RW ;
Anderson, JL ;
Cannon, RO ;
Criqui, M ;
Fadl, YY ;
Fortmann, SP ;
Hong, Y ;
Myers, GL ;
Rifai, N ;
Smith, SC ;
Taubert, K ;
Tracy, RP ;
Vinicor, F .
CIRCULATION, 2003, 107 (03) :499-511
[13]  
SARTOR G, 1995, INT J CLIN PHARM TH, V33, P3
[14]   C-reactive protein in hypertension: clinical significance and predictive value [J].
Schillaci, Giuseppe ;
Pirro, Matteo .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (07) :500-508
[15]   C-reactive protein and the risk of developing hypertension [J].
Sesso, HD ;
Buring, JE ;
Rifai, N ;
Blake, GJ ;
Gaziano, JM ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (22) :2945-2951
[16]   Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off atorvastatin for short time intervals [J].
Thomas, MK ;
Narang, D ;
Lakshmy, R ;
Gupta, R ;
Naik, N ;
Maulik, SK .
CARDIOVASCULAR DRUGS AND THERAPY, 2006, 20 (01) :37-44